Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.78 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.78 |
| ▸ | HTT | P42858 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | GRM5 | P41594 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 2/20 | 0.54 |
| ▸ | ANPEP | P15144 | 2/20 | 0.54 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5783791 | 0.94 | ALDH1A1 (0.71) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL3427705 | 0.93 | ALDH1A1 (0.74) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL3427969 | 0.93 | ALDH1A1 (0.70) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL19691213 | 0.92 | ALDH1A1 (0.69) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL19691212 | 0.92 | ALDH1A1 (0.69) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL12424958 | 0.92 | ALDH1A1 (0.69) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL10143960 | 0.92 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL4414127 | 0.92 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3194885 | 0.91 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3194878 | 0.91 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897866-B1 | AN ANTIMICROBIAL COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-11-05 | — | — | EP | claimed |
| US-12311044-B2 | Antimicrobial composition | CONOPCO, INC. (US) | 2025-05-27 | — | — | US | claimed |
| CN-119654130-A | Use of a composition for enhancing night repair related functions of skin | 联合利华知识产权控股有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-117915890-A | Deodorant composition | 联合利华知识产权控股有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-113242751-B | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-111787903-B | Disinfectant composition | 联合利华知识产权控股有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20220087914-A1 | AN ANTIMICROBIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2022-03-24 | — | — | US | claimed |
| EP-3897866-A1 | AN ANTIMICROBIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2021-10-27 | — | — | EP | claimed |
| CN-113242751-A | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2021-08-10 | — | — | CN | claimed |
| WO-2020126347-A1 | AN ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2020-06-25 | — | — | WO | claimed |
| US-8163771-B2 | 11 β-HSD1 modulators | EXELIXIS, INC. (US) | 2012-04-24 | — | — | US | claimed |
| EP-2308874-A1 | Useful beta-lactamase inhibitors | Basilea Pharmaceutica AG (CH) | 2011-04-13 | — | — | EP | claimed |
| EP-2280966-A1 | AZABICYCLO [3.2.1]OCTYL DERIVATIVES AS 11 BETA-HSD1 MODULATORS | Exelixis, Inc. (US) | 2011-02-09 | — | — | EP | claimed |
| US-20100105675-A2 | 11 BETA-HSD1 MODULATORS | EXELIXIS, INC. (US) | 2010-04-29 | — | — | US | claimed |
| US-20090247515-A1 | 11 Beta-HSD1 Modulators | EXELIXIS, INC. (US) | 2009-10-01 | — | — | US | claimed |
| WO-2009114173-A1 | AZABICYCLO [3. 2. I] OCTYL DERIVATIVES AS 11 BETA-HSDL MODULATORS | EXELIXIS, INC. (US) | 2009-09-17 | — | — | WO | claimed |
| WO-2006068410-A1 | NOVEL 3-(2-AMINO-6-PYRIDINYL)-4-HYDROXYPHENYL AMINE DERIVATIVES | LG LIFE SCIENCES, LTD. (KR) | 2006-06-29 | — | — | WO | claimed |
| EP-4702006-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS XVI | BASF SE (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-4436912-A | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor | ELI LILLY AND COMPANY (US) | 1984-03-13 | — | — | US | disclosed |
| US-4430499-A | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1984-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105675-A2 | 11 BETA-HSD1 MODULATORS | HSD11B1, HSD11B2, HSD3B1 | ALDH1A1 53/4885L3MBTL1 2364/4885HTT 2641/4885 |
| US-12311044-B2 | Antimicrobial composition | DPM1, THPO, FPR1 | ALDH1A1 2349/4885L3MBTL1 2696/4885HTT 3103/4885 |
| US-20090247515-A1 | 11 Beta-HSD1 Modulators | HSD11B1, HSD11B2, HSD3B1 | ALDH1A1 68/4885L3MBTL1 2934/4885HTT 2632/4885 |
| US-20220087914-A1 | AN ANTIMICROBIAL COMPOSITION | THPO, BROX, FPR1 | ALDH1A1 2160/4885L3MBTL1 2800/4885HTT 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.